RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.8830
+0.0180 (2.08%)
At close: Feb 27, 2026, 4:00 PM EST
0.8807
-0.0023 (-0.26%)
After-hours: Feb 27, 2026, 7:50 PM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $32.36 million as of February 27, 2026. Its market cap has decreased by -21.56% in one year.
Market Cap
32.36M
Enterprise Value
22.55M
1-Year Change
-21.56%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $32.36M, a decrease of -52.85%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 32.36M | 5.11% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 35.98M |
| Pluri | 35.88M |
| Actinium Pharmaceuticals | 35.25M |
| Rein Therapeutics | 34.57M |
| Lantern Pharma | 33.33M |
| Rallybio | 31.97M |
| Werewolf Therapeutics | 31.11M |
| Tempest Therapeutics | 30.87M |